EATG » Projects » European HIV Vaccine Alliance – EHVA

European HIV Vaccine Alliance – EHVA

b11769e924

The European HIV Vaccine Alliance (EHVA) program has as major goal to develop a Multidisciplinary Vaccine Platform (MVP) in the fields of prophylactic and therapeutic HIV vaccines.

The MVP includes four components: 1) Discovery, 2) Immune Profiling, 3) Data Management, Integration and Down-Selection, and 4) Clinical Trials in the field of HIV vaccines.

Project aims: The Specific Objectives of the MVP are to build up: 1) Discovery Platform. 2) Immune Profiling Platform 3) Data Management/Integration/Down-Selection Platform 4) Clinical Trials Platform.

Duration: 60 months from January 2016

Project leader: Institut national de la santé et de la recherche médicale (INSERM)

Main partners: Involves 39 institutions including universities, research institutes, SMEs, patient organisations and larger industries.

EATG participation: Involved in WP 8: Therapeutic Vaccine Trials; WP 10: Dissemination and Exploitation. EATG is community partner in this project ensuring community feedback to the scientific developments within the project.

Main funding source: EC Horizon 2020

EATG contact person(s): Giorgio Barbareschi (EATG Office) at giorgio.barbareschi@eatg.org; Giulio M Corbelli (EATG membership) at giuliomariacorbelli@gmail.com

Website: http://www.ehv-a.eu/index.php

1st Newsletter July 2016

Share on FacebookTweet about this on TwitterShare on Google+Pin on PinterestShare on LinkedIn